10-Q Filing

HealthLynked Corp CIK: 1680139 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-022223`
Period End Date	20200630
Filing Date	20200814
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	hlyk-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 100 Cash Flow Statement 113 Stockholders Equity 47

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$749.32K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$356.08K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$794.89K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$5.91K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$10.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2020 and December 31, 2019, respectively	`AccountsReceivableNetCurrent`	$158.09K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2020 and December 31, 2019, respectively	`AccountsReceivableNetCurrent`	$83.25K	USD	Point-in-time
Inventory	`InventoryNet`	$105.20K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$212.25K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$777.67K	USD	Point-in-time
Inventory	`InventoryNet`	$70.46K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$119.33K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$58.99K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$19.20K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$402.68K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$678.36K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	131.25M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	109.89M	shares	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $794,888 and $749,316 as of June 30, 2020 and December 31, 2019, respectively	`PropertyPlantAndEquipmentNet`	$513.79K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $794,888 and $749,316 as of June 30, 2020 and December 31, 2019, respectively	`PropertyPlantAndEquipmentNet`	$471.26K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	109.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	131.25M	shares	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $9,997 and $5,908 as of June 30, 2020 and December 31, 2019, respectively	`IntangibleAssetsNetIncludingGoodwill`	$2.59M	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $9,997 and $5,908 as of June 30, 2020 and December 31, 2019, respectively	`IntangibleAssetsNetIncludingGoodwill`	$1.34M	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.05M	shares	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$177.87K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$293.12K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.93M	shares	Point-in-time
Total Assets	`Assets`	$2.55M	USD	Point-in-time
Total Assets	`Assets`	$3.91M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$658.97K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$836.47K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$106.28K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$82.75K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$201.52K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$525.67K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$493.46K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$827.98K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$743.96K	USD	Point-in-time
Government notes payable	`OtherNotesPayable`	-	USD	Point-in-time
Government notes payable	`OtherNotesPayable`	$745.87K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $212,246 and $777,668 as of June 30, 2020 and December 31, 2019, respectively	`ConvertibleDebtCurrent`	$1.54M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $212,246 and $777,668 as of June 30, 2020 and December 31, 2019, respectively	`ConvertibleDebtCurrent`	$1.91M	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$100.00K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$986.33K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$257.38K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$991.29K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$6.10M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.91M	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$400.00K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$369.44K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$80.51K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$86.50K	USD	Point-in-time
Total Liabilities	`Liabilities`	$5.39M	USD	Point-in-time
Total Liabilities	`Liabilities`	$6.55M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 131,251,775 and 109,894,490 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$13.12K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 131,251,775 and 109,894,490 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$10.99K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,925,839 and 1,047,904 shares as of June 30, 2020 and December 31, 2019, respectively	`CommonStockIssuableValue`	$212.94K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,925,839 and 1,047,904 shares as of June 30, 2020 and December 31, 2019, respectively	`CommonStockIssuableValue`	$159.54K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$13.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$15.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-18.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.03M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$2.55M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$3.91M	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.45M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.21M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.11M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.67M	USD	2 Qtrs
Consulting revenue	`ConsultingRevenue`	$50.42K	USD	1 Quarter
Consulting revenue	`ConsultingRevenue`	$50.42K	USD	2 Qtrs
Consulting revenue	`ConsultingRevenue`	-	USD	1 Quarter
Consulting revenue	`ConsultingRevenue`	-	USD	2 Qtrs
Total revenue	`Revenues`	$1.16M	USD	1 Quarter
Total revenue	`Revenues`	$1.67M	USD	2 Qtrs
Total revenue	`Revenues`	$1.21M	USD	1 Quarter
Total revenue	`Revenues`	$2.50M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$703.85K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.32M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.05M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$555.09K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$521.55K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.08M	USD	2 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$766.09K	USD	2 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$521.02K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$64.24K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$64.24K	USD	2 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	-	USD	2 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	-	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.16M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$646.31K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$659.47K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.35M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$49.66K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$24.87K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$21.71K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$23.36K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.68M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.19M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.81M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.91M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.52M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-650.02K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.18M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-698.19K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-896.37K	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-67.36K	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$72.44K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-428.44K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-30.41K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-60.11K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-155.67K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-119.70K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$121.23K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$87.33K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-172.95K	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-299.61K	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-465.11K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-479.00K	USD	2 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$-13.67K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$726.68K	USD	2 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$223.88K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$415.51K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-38.69K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-45.31K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	1 Quarter
Interest expense	`InterestExpenseOther`	$58.42K	USD	1 Quarter
Interest expense	`InterestExpenseOther`	$120.60K	USD	2 Qtrs
Interest expense	`InterestExpenseOther`	$106.67K	USD	2 Qtrs
Interest expense	`InterestExpenseOther`	$60.34K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-181.38K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-867.83K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-920.41K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-418.85K	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.52M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-879.57K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.94M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.10M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-879.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.53M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.54M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	120.07M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	98.50M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.50M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	120.07M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.53M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.54M	shares	1 Quarter

Cash Flow Statement 113 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-879.57K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$49.66K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$24.87K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$21.71K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$23.36K	USD	2 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$207.78K	USD	2 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$317.29K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-172.95K	USD	1 Quarter
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-299.61K	USD	1 Quarter
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-465.11K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-479.00K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$121.23K	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$87.33K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$415.51K	USD	2 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$726.68K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-896.37K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-67.36K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$72.44K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-428.44K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$155.67K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$30.41K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$60.11K	USD	2 Qtrs
Change in fair value of debt	`NoncashExpense`	$119.70K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-38.69K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-45.31K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$9.21K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-15.36K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$21.47K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$34.74K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.38K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-74.67K	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$133.05K	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$159.51K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$133.27K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-141.53K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$156.08K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$128.08K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$32.21K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$33.49K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$2.25K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.09M	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$164.00K	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$465.00K	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	-	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$47.00K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.04K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.30K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-214.05K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-469.30K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$994.27K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$724.69K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$200.00	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.02M	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	2 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$746.76K	USD	2 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$404.42K	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	-	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$149.00K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$151.44K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$745.87K	USD	2 Qtrs
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.55M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.62M	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$245.64K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-10.04K	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$356.08K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$125.74K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$356.08K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$125.74K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$15.59K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$29.34K	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$804.06K	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$25.00	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$54.26K	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$673.99K	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.04M	USD	2 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$17.18K	USD	2 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	-	USD	2 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$221.00	USD	2 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	-	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$560.05K	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$43.30K	USD	2 Qtrs
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$1.00M	USD	2 Qtrs
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$201.68K	USD	2 Qtrs
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$500.00K	USD	2 Qtrs
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$1.06M	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$288.57K	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$115.65K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$103.07K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$267.81K	USD	2 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	2 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	2 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	-	USD	2 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	$225.32K	USD	2 Qtrs

Stockholders Equity 47 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Acquisition of Cura Health Management LLC	`StockIssuedDuringPeriodValueAcquisition`	$201.68K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$253.78K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$694.16K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$348.60K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$145.46K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$88.83K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$33.48K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$139.07K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$15.58K	USD	1 Quarter
Fair value of warrants allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$225.32K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$12.50K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$4.68K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$54.26K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	-	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$533.28K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$138.76K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$535.23K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$652.56K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$26.84K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$64.35K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$43.70K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$66.88K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$38.58K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$61.23K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$59.40K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$39.41K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	-	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$200.00	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-580.22K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-879.57K	USD	1 Quarter
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Acquisition of Hughes Center for Functional Medicine	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.